FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

ACCENTIA BIOPHARMACEUTICALS INC: cost_of_revenue

One fact, its scope and the complete path back to the official record.

Period: 2012-01-01 – 2012-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/6b914a7b-b331-42fa-b222-dbe8c41d461d

Reported value

$793.961k{"amount": 793961, "concept": "us-gaap:CostOfRevenue", "currency": "USD"}
Entity
ACCENTIA BIOPHARMACEUTICALS INC
Metric
cost_of_revenue
Period
2012-01-01 – 2012-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001193125-12-234732 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T12:29:31.997734+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001310094/cost-of-revenue/2012-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.